Physician profile
Diane L Wren
NPI 1811069628
$339.40
in general payments reported to CMS, 2019-2025
9 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.31 · 2022: $36.64 · 2023: $72.84 · 2024: $73.56 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $128.05 | 2025 | Esophyx |
| Abbott Laboratories | $80.97 | 2022-2024 | Freestyle Libre 3, Proclaim |
| Pfizer INC. | $28.31 | 2021 | |
| Janssen Pharmaceuticals, INC | $22.01 | 2023 | Spravato |
| Novo Nordisk INC | $18.84 | 2024 | Ozempic |
| Lilly USA, LLC | $16.88 | 2024 | Zepbound, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.53 | 2023 | Xifaxan, Trulance |
| Currax Pharmaceuticals LLC | $14.45 | 2024 | Contrave |
| Glaxosmithkline, LLC. | $14.36 | 2023 | Shingrix, Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Wren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.